Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)

SHE:300267 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 16, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,456	5,734	6,621	7,322	9,777	8,684
Market Cap Growth	-4.07%	-13.40%	-9.58%	-25.11%	12.59%	-18.41%
Enterprise Value	6,122	5,344	6,256	7,251	9,643	8,585
Last Close Price	3.13	2.78	3.21	3.52	4.70	4.12
PE Ratio	-	-	-	159.37	-	45.16
Forward PE	-	38.54	38.54	38.54	38.54	38.54
PS Ratio	5.30	5.03	3.71	3.92	4.37	3.65
PB Ratio	1.46	1.30	1.38	1.45	2.01	1.49
P/TBV Ratio	1.57	1.41	1.49	1.58	2.22	1.66
P/FCF Ratio	-	-	-	68.10	-	-
P/OCF Ratio	42.52	34.40	44.61	26.06	105.49	76.52
EV/Sales Ratio	5.03	4.69	3.51	3.88	4.31	3.60
EV/EBITDA Ratio	46.43	52.75	386.29	45.89	234.66	32.07
EV/EBIT Ratio	-	-	-	-	-	112.49
EV/FCF Ratio	-281.86	-	-	67.43	-	-
Debt / Equity Ratio	0.10	0.12	0.07	0.08	0.05	0.08
Debt / EBITDA Ratio	3.20	4.75	16.27	2.43	5.41	1.73
Debt / FCF Ratio	-	-	-	3.75	-	-
Asset Turnover	0.23	0.21	0.32	0.33	0.37	0.37
Inventory Turnover	1.34	1.32	1.99	1.90	2.61	2.34
Quick Ratio	1.50	1.45	1.56	1.53	2.10	2.27
Current Ratio	2.71	2.43	2.87	2.88	3.90	3.55
Return on Equity (ROE)	-8.02%	-8.52%	-4.50%	0.75%	-14.90%	3.10%
Return on Assets (ROA)	-0.75%	-1.06%	-2.02%	-0.12%	-1.56%	0.74%
Return on Capital (ROIC)	-0.80%	-1.12%	-2.16%	-0.13%	-1.65%	0.78%
Return on Capital Employed (ROCE)	-	-	-	-	-	1.30%
Earnings Yield	-5.39%	-6.51%	-2.95%	0.63%	-8.09%	2.21%
FCF Yield	-0.34%	-0.50%	-1.36%	1.47%	-2.63%	-5.56%
Dividend Yield	-	-	-	0.85%	-	1.21%
Payout Ratio	-	-	-	10.29%	-	21.62%
Buyback Yield / Dilution	0.08%	-0.01%	-0.11%	0.11%	0.04%	-0.08%
Total Shareholder Return	0.08%	-0.01%	-0.11%	0.96%	0.04%	1.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.